Share
Seeger Weiss is pleased to announce partners Chris Seeger, Stephen Weiss, David Buchanan, and Jennifer Scullion have been named to the 2024 Lawdragon 500 Leading Global Litigators list. This prestigious guide seeks to honor the top 500 international litigators who excel in resolving global disputes, emphasizing their expertise and the strategic approaches of their law firms.
Chris Seeger, co-founding partner of Seeger Weiss, has consistently appeared on several Lawdragon guides and was named a “Lawdragon Legend” in 2016. Throughout his career, Seeger has led some of the most complex, groundbreaking, and high-profile litigations that have shaped the world for the better. In 2023, Seeger achieved remarkable success, securing significant settlements for injured plaintiffs in complex cases. As co-lead counsel on the 3M Combat Arms Earplug Litigation, he negotiated a settlement exceeding $6 billion. Additionally, he finalized settlements worth over $533.5 million in the Proton Pump Inhibitor Litigation. Chris was appointed Co-lead Counsel by Judge Joy Flowers Conti to lead the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator litigation. In this case, he secured a $1.075 billion personal injury settlement and a $25 million medical monitoring settlement. This is in addition to securing an uncapped economic loss settlement worth a minimum of $550 million.
Stephen Weiss, co-founding partner of Seeger Weiss, chairs the firm’s qui tam/whistleblower practice, representing relators in some of the nation’s largest recoveries under federal and state false claims acts, focusing on health care and tax fraud. He has litigated against CareCore National, Warner Chilcott, and Life Spine, Inc., and led the first settlement under the 2010 tax whistleblower amendments to New York’s False Claims Act. In March 2023, he played a key role in the $10 million False Claims Act settlement against medical device company Stimwave. His practice also includes high-profile multidistrict litigations, arbitrations, and private business disputes in various legal areas, including consumer products, insurance, agricultural, environmental, securities, employment, and property rights litigation.
Senior partner Dave Buchanan represents individual and corporate plaintiffs in state and federal courts. Recently, he was appointed co-lead counsel for the Self-Funded Payer Track in the In re: Insulin Pricing Litigation. Dave has also served on the plaintiffs’ steering committee in the 3M Combat Arms Earplug Litigation, the largest mass tort in American history, and on the plaintiffs’ executive committee in the NFL Concussion Litigation. Additionally, he was co-chair of discovery and lead counsel in several bellwether trials in the Vioxx Litigation.
For over twenty years, Jen has led complex litigations, arbitrations, and appeals for U.S. and multinational clients across various areas, including antitrust, consumer fraud, communications, civil rights, and international bondholder disputes. Currently, she is a member of the Plaintiffs’ Executive Committee, Settlement Committee, Manufacturers’ Committee, and Law & Briefing Committee in the National Prescription Opiate Litigation. This multidistrict litigation prosecutes RICO, public nuisance, and related claims on behalf of local governments. Additionally, Jen serves as co-lead counsel for the negotiation class.
Lawdragon’s selection is a time-honored methodology performed through independent journalistic research and submissions. Decisions are carefully made based on factors including research of top verdicts and settlements, peer recognition, and interviews with lawyers nationwide. The selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
Prior results do not guarantee or predict a similar outcome in any future matter.